![Addressing the risk domain in the long‐term management of pediatric asthma - Hamelmann - 2020 - Pediatric Allergy and Immunology - Wiley Online Library Addressing the risk domain in the long‐term management of pediatric asthma - Hamelmann - 2020 - Pediatric Allergy and Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a9752e55-8415-4267-903b-f98a0c6c5290/pai.v31.3.cover.jpg?trick=1676268483964)
Addressing the risk domain in the long‐term management of pediatric asthma - Hamelmann - 2020 - Pediatric Allergy and Immunology - Wiley Online Library
![Section 4, Managing Asthma Long Term: Overview - Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma - NCBI Bookshelf Section 4, Managing Asthma Long Term: Overview - Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-asthma3-lrg.png)
Section 4, Managing Asthma Long Term: Overview - Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma - NCBI Bookshelf
![Figure 4-1b, [STEP WISE APPROACH FOR MANAGING ASTHMA IN CHILDREN 5–11 YEARS OF AGE]. - Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma - NCBI Bookshelf Figure 4-1b, [STEP WISE APPROACH FOR MANAGING ASTHMA IN CHILDREN 5–11 YEARS OF AGE]. - Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK7229/bin/section4_managing1f4-1b.jpg)
Figure 4-1b, [STEP WISE APPROACH FOR MANAGING ASTHMA IN CHILDREN 5–11 YEARS OF AGE]. - Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma - NCBI Bookshelf
![Sanofi on Twitter: "With @Regeneron, we are at #ERSCongress sharing data on the long-term management of asthma and type 2 inflammation biomarkers. Explore the virtual sessions on #asthma to learn more. https://t.co/837ZKB2A0Y" / Sanofi on Twitter: "With @Regeneron, we are at #ERSCongress sharing data on the long-term management of asthma and type 2 inflammation biomarkers. Explore the virtual sessions on #asthma to learn more. https://t.co/837ZKB2A0Y" /](https://pbs.twimg.com/media/EhYEsCIXcAAfM33.jpg)